Martek Biosciences has reached a settlement with Capsugel France that will see the supplement maker purchase all its algal DHA exclusively from Martek.
The news draws to a close Martek’s patent infringement action, which was filed in the High Court of Strasbourg, France, last year.
Additionally, Martek and Capsugel will jointly develop a product containing Martek’s algal DHA in Capsugel’s proprietary Licaps liquid-filled hard capsules, the companies revealed.
This settlement agreement between Martek and Capsugel does not include Martek’s action against Lonza, which continues, Martek said.

US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData